SLDB
NASDAQ
$8.46
Solid Biosciences Inc (SLDB)
Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $17.50 (+106.86%)
Market Cap
$947M
FCF 5Y CAGR
+28.71%
Free Cash Flow Yield
-18.26%
Beta (5Y)
1.77
Price Chart
Valuation
Market Cap$947M
P/S3.65
P/B2.53
Profitability
Gross Profit (TTM)-$96M
EBITDA-$195M
EPS-$2.30
Financial Health
Free Cash Flow Yield-18.26%
Growth & Risk
FCF 5Y CAGR+28.71%
Beta (5Y)1.77
Sharpe Ratio0.70